Researchers saw 95% fewer cases than expected; model offered antiretroviral meds to HIV-infected members and preventive therapy for uninfected partners
Providing HIV medication to both members of a HIV-serodiscordant couple substantially reduced the risk of transmission within that couple, according to a study published Aug. 23 in PLOS Medicine.
By Katherine Tweed
Coal combustion is the single largest source of air pollution-related deaths in China as of 2013. But the steady path toward cleaner sources of energy for power production and industrial use may not substantially curb the problem in the coming decades, according to a new study.
Students share their experiences in a study abroad program examining health disparities in Great Britain in this School of Public Health news article. The program name, Dark Empire, refers to the shadow that existed after the fall of the British Empire and the health disparities seen today as a result of British imperialism. This is the program's 9th year and it is led by Adjunct Professor Clarence Spigner.
By Heather Boerner
CAPE TOWN, South Africa — From where Linda-Gail Bekker sits as director of the Desmond Tutu HIV Centre in Cape Town, science has been losing ground against HIV for years, especially when it comes to young women. After all, in some parts of the country, girls who are 15 today have an 80 percent chance of acquiring HIV in their lifetimes.
“We’re really in the trenches here,” she said. “We have to bring all the technology, tools—you know, innovations—we can find to start turning that war around.”
By Andrea Woo
A University of Victoria researcher says she and a colleague are close to developing a vaccine for syphilis, a disease that has reached its highest rates in B.C. in 30 years.
Microbiologist Caroline Cameron and Sheila Lukehart, a professor in the University of Washington’s department of global health, have received a nearly $3-million grant from the U.S. National Institute of Allergy and Infectious Diseases at the National Institutes of Health. The grant will help fund preclinical trials.
By Richard Watts
A University of Victoria microbiologist and her American colleague are looking for a vaccine to prevent syphilis, a venereal disease on the rise worldwide.
UVic’s Caroline Cameron, a professor of biochemistry and microbiology, is joining with University of Washington’s Sheila Lukehart, a professor of medicine and global health, to develop a vaccine to stop syphilis before it gets started in a body.
“It’s a preventive treatment, not a cure,” Cameron said.
Professor Ali Mokdad of the Institute for Health Metrics and Evaluation authored this opinion piece on the lack of data on adolescent health, and how this prevents our abilities to improve health among this vulnerable population.
By Emma Grey Ellis
To talk about Zika virus control is to talk about money. Vaccine development, mosquito abatement, and even the distribution of DEET repellant takes (and currently lacks) major federal dollars. When, last week, the US Department of Health and Human Services declared Zika a public health emergency in Puerto Rico, it was in part a means to a better-funded end.
By Bob Young
While pot advocates were disappointed by the federal government’s decision to keep marijuana classified as a dangerous drug with no medical use, there is potential research-related benefit in Thursday’s news for Washington.
Adjunct Professor Dennis Donovan is quoted in this Seattle Times story.
By Coral Garnick
The University of Washington, in partnership with the Kenya Medical Research Institute, is part of the largest clinical trial, to date, examining diarrhea management.